# Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms

> **NCT03929497** · PHASE2 · TERMINATED · sponsor: **H. Lundbeck A/S** · enrollment: 96 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Lu AF11167

## Key facts

- **NCT ID:** NCT03929497
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-04-22
- **Primary completion:** 2020-09-01
- **Final completion:** 2020-09-14
- **Target enrollment:** 96 (ACTUAL)
- **Why stopped:** Lack of efficacy based on the interim analysis in the 17972A study
- **Last updated:** 2020-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03929497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03929497, "Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03929497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*